Mendelian randomisation studies of Attention Deficit Hyperactivity Disorder.
ADHD
causal inference
mendelian randomisation
Journal
JCPP advances
ISSN: 2692-9384
Titre abrégé: JCPP Adv
Pays: United States
ID NLM: 9918250414706676
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
received:
26
07
2022
accepted:
15
09
2022
medline:
11
7
2023
pubmed:
11
7
2023
entrez:
11
7
2023
Statut:
epublish
Résumé
Observational studies have found Attention Deficit Hyperactivity Disorder (ADHD) to be associated with an increased risk of adverse outcomes as well as with early risk factors; however it is not clear whether these associations reflect causal effects. Alternatives to traditional observational studies are needed to investigate causality: one such design is Mendelian randomization (MR), which uses genetic variants as instrumental variables for the exposure. In this review we summarise findings from approximately 50 studies using MR to examine potentially causal associations with ADHD as either an exposure or outcome. To-date, few MR ADHD studies have investigated causal evidence with other neurodevelopmental, mental health and neurodegenerative conditions but those that have suggest a complex relationship with autism, some evidence of a causal effect on depression and limited evidence of a causal effect on neurodegenerative conditions. For substance use, MR studies provide evidence consistent with a causal effect of ADHD on smoking initiation, but findings for other smoking behaviours and cannabis use are less consistent. Studies of physical health suggest bidirectional causal effects with higher body mass index, with stronger effects for childhood obesity, as well as some evidence of causal effects on coronary artery disease and stroke in adults and limited evidence of causal effects on other physical health problems or sleep. Studies suggest bidirectional relationships between ADHD and socio-economic markers and provide some evidence that low birthweight may be a causal risk factor for ADHD, while bidirectional evidence has been found for some environmental factors. Finally, there is emerging evidence of bidirectional causal links between ADHD genetic liability and biological markers of human metabolism and inflammation. While MR has advantages over traditional observational designs in addressing causality, we discuss limitations of current ADHD studies and future directions, including the need for larger genome-wide association studies (and using samples of different ancestries), and for triangulation with different methods.
Sections du résumé
Background
UNASSIGNED
Observational studies have found Attention Deficit Hyperactivity Disorder (ADHD) to be associated with an increased risk of adverse outcomes as well as with early risk factors; however it is not clear whether these associations reflect causal effects. Alternatives to traditional observational studies are needed to investigate causality: one such design is Mendelian randomization (MR), which uses genetic variants as instrumental variables for the exposure.
Methods
UNASSIGNED
In this review we summarise findings from approximately 50 studies using MR to examine potentially causal associations with ADHD as either an exposure or outcome.
Results
UNASSIGNED
To-date, few MR ADHD studies have investigated causal evidence with other neurodevelopmental, mental health and neurodegenerative conditions but those that have suggest a complex relationship with autism, some evidence of a causal effect on depression and limited evidence of a causal effect on neurodegenerative conditions. For substance use, MR studies provide evidence consistent with a causal effect of ADHD on smoking initiation, but findings for other smoking behaviours and cannabis use are less consistent. Studies of physical health suggest bidirectional causal effects with higher body mass index, with stronger effects for childhood obesity, as well as some evidence of causal effects on coronary artery disease and stroke in adults and limited evidence of causal effects on other physical health problems or sleep. Studies suggest bidirectional relationships between ADHD and socio-economic markers and provide some evidence that low birthweight may be a causal risk factor for ADHD, while bidirectional evidence has been found for some environmental factors. Finally, there is emerging evidence of bidirectional causal links between ADHD genetic liability and biological markers of human metabolism and inflammation.
Conclusions
UNASSIGNED
While MR has advantages over traditional observational designs in addressing causality, we discuss limitations of current ADHD studies and future directions, including the need for larger genome-wide association studies (and using samples of different ancestries), and for triangulation with different methods.
Identifiants
pubmed: 37431426
doi: 10.1002/jcv2.12117
pii: JCV212117
pmc: PMC10242846
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e12117Informations de copyright
© 2022 The Authors. JCPP Advances published by John Wiley & Sons Ltd on behalf of Association for Child and Adolescent Mental Health.
Déclaration de conflit d'intérêts
The authors have declared that they have no competing or potential conflicts of interest.
Références
J Child Psychol Psychiatry. 1999 Jan;40(1):57-87
pubmed: 10102726
Lancet Psychiatry. 2021 May;8(5):373-386
pubmed: 33740410
Am J Med Genet B Neuropsychiatr Genet. 2021 Oct;186(7):423-429
pubmed: 32909657
Front Genet. 2021 Oct 19;12:741429
pubmed: 34737764
J Child Psychol Psychiatry. 2014 Oct;55(10):1068-87
pubmed: 25132410
Eur Neuropsychopharmacol. 2020 Aug;37:49-63
pubmed: 32565043
Int J Epidemiol. 2021 May 17;50(2):496-509
pubmed: 33221865
Dev Psychopathol. 2018 Aug;30(3):1107-1128
pubmed: 30068414
BMC Health Serv Res. 2021 Oct 8;21(1):1063
pubmed: 34625073
Nat Genet. 2016 May;48(5):481-7
pubmed: 27019110
Psychiatry Res. 2022 Aug;314:114679
pubmed: 35717853
Front Psychiatry. 2021 Oct 20;12:746276
pubmed: 34744839
J Am Acad Child Adolesc Psychiatry. 1987 Sep;26(5):728-32
pubmed: 3667503
Nat Genet. 2014 Jun;46(6):543-550
pubmed: 24816252
Nature. 2018 Jun;558(7708):73-79
pubmed: 29875488
Int J Obes (Lond). 2019 Dec;43(12):2500-2508
pubmed: 31000774
Clin Rheumatol. 2021 Sep;40(9):3729-3733
pubmed: 33786690
J Am Acad Child Adolesc Psychiatry. 2017 Jul;56(7):556-569
pubmed: 28647007
Eur Respir J. 2019 Dec 19;54(6):
pubmed: 31619474
J Pediatr Psychol. 2007 Jul;32(6):643-54
pubmed: 17569716
Psychol Med. 2021 Oct;51(13):2274-2286
pubmed: 33814023
J Child Psychol Psychiatry. 2009 Dec;50(12):1468-76
pubmed: 19508494
Mol Psychiatry. 2020 Oct;25(10):2493-2503
pubmed: 30610198
Int J Epidemiol. 2016 Dec 1;45(6):1866-1886
pubmed: 28108528
Front Genet. 2020 Dec 16;11:608630
pubmed: 33424931
Drug Alcohol Depend. 2018 Oct 1;191:338-342
pubmed: 30173087
Sci Rep. 2015 Nov 16;5:16645
pubmed: 26568383
Addict Biol. 2021 Jan;26(1):e12849
pubmed: 31733098
J Clin Med. 2019 Nov 21;8(12):
pubmed: 31766499
World J Biol Psychiatry. 2021 Dec;22(10):778-791
pubmed: 33821771
Epidemiol Psychiatr Sci. 2022 Apr 25;31:e26
pubmed: 35465862
Nat Genet. 2019 Jan;51(1):63-75
pubmed: 30478444
Int J Epidemiol. 2023 Apr 19;52(2):386-402
pubmed: 35690959
EBioMedicine. 2022 Apr;78:103948
pubmed: 35306338
Int J Stroke. 2023 Mar;18(3):346-353
pubmed: 35670701
PLoS Med. 2020 Jun 1;17(6):e1003137
pubmed: 32479557
J Child Psychol Psychiatry. 2013 Jan;54(1):3-16
pubmed: 22963644
Schizophr Bull. 2020 Jul 8;46(4):804-813
pubmed: 31919502
Eur J Nutr. 2021 Aug;60(5):2581-2591
pubmed: 33245439
J Child Psychol Psychiatry. 2021 Nov;62(11):1285-1296
pubmed: 34235737
Am J Epidemiol. 2021 Jun 1;190(6):1047-1055
pubmed: 33324987
Am J Hum Genet. 2017 Jan 5;100(1):40-50
pubmed: 27989323
Hum Mol Genet. 2014 Sep 15;23(R1):R89-98
pubmed: 25064373
Transl Psychiatry. 2022 Oct 1;12(1):422
pubmed: 36182936
Lancet. 2016 Mar 19;387(10024):1240-50
pubmed: 26386541
Psychol Med. 2021 Aug;51(11):1890-1897
pubmed: 32249726
Eur Psychiatry. 2019 Aug;60:79-85
pubmed: 31234011
Nat Genet. 2018 Jul;50(7):912-919
pubmed: 29942086
Arch Gen Psychiatry. 2012 Dec;69(12):1295-303
pubmed: 23070149
BMC Med. 2022 Apr 11;20(1):106
pubmed: 35399077
Nat Commun. 2019 Dec 18;10(1):5765
pubmed: 31852892
Am J Med Genet B Neuropsychiatr Genet. 2021 Apr;186(3):140-150
pubmed: 33244849
Br J Psychiatry. 2021 Sep;219(3):507-514
pubmed: 33583444
Prog Neuropsychopharmacol Biol Psychiatry. 2022 Jun 8;116:110534
pubmed: 35150783
Psychol Med. 2022 Apr;52(5):968-978
pubmed: 32762793
Transl Psychiatry. 2021 Sep 4;11(1):455
pubmed: 34482360
Int J Epidemiol. 2018 Aug 1;47(4):1207-1216
pubmed: 29800128
Int J Epidemiol. 2022 Jan 6;50(6):2011-2023
pubmed: 34999873
J Child Psychol Psychiatry. 2013 Oct;54(10):1038-46
pubmed: 24007415
Hum Genet. 2021 Sep;140(9):1267-1281
pubmed: 33973063
Hum Mol Genet. 2018 Aug 1;27(R2):R195-R208
pubmed: 29771313
Twin Res Hum Genet. 2018 Dec;21(6):485-494
pubmed: 30587273
J Atten Disord. 2018 Feb;22(3):203-228
pubmed: 27664125
Brain Sci. 2021 Aug 06;11(8):
pubmed: 34439661
Autism Res. 2022 Jun;15(6):1008-1017
pubmed: 35384380
Neuropsychobiology. 2022;81(6):484-496
pubmed: 35764056